Compound ID | 775
Class: Protein synthesis inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Inhibits the elongation Factor Tu. Effective against Gram positive staphylocci and enterococci |
Description: | N'-p-octyloxybenzylglycyl-vancomycin |
Institute where first reported: | Chiron Corp. (Novartis, Switzerland) |
Year first mentioned: | 2005 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
External links: | |
Citation: |